Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT03597568
Eligibility Criteria:
Inclusion Criteria:
* CKD stage III (estimated GFR: 30-60 mL/MIN/1.73m2)
* Able to give informed consent
* Angiotensin converting enzyme inhibitor or angiotensin II receptor bloocker for \> 3 month prior to the study
* Type II diabetes mellitus
Exclusion Criteria:
* Consuming \> 2 glasses/day red wine and/or taking resveratrol or vitamin C supplement in the past 12 months
* Life expectancy \<1 year
* BMI \>40 kg/m2 1
* Pregnant, breastfeeding, or unwilling to use adequate birth control
* Uncontrolled hypertension; blood pressure \> 140/90
* Uncontrolled type II DM; AIC \> 8.5
* Currently taking anticoagulants including: coumadin, dalteparin, enoxaparin, haparin, and plavix.
* Severe liver disease
* Severe systolic heart failure
* Hospitalization within the last 3 months
* Active infection or antibiotic therapy
* Immunosuppressive therapy within the last year
* Currently partaking in another research study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
80 Years
Study:
NCT03597568
Study Brief:
Protocol Section:
NCT03597568